These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19303737)

  • 1. [Biotherapy of auto-immune diseases : past, present and future perspectives].
    Arnaud L; Haroche J; Piette JC; Amoura Z
    Presse Med; 2009 May; 38(5):749-60. PubMed ID: 19303737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rituximab: a original biotherapy in auto-immune disorders].
    Sibilia J; Sordet C
    Rev Med Interne; 2005 Jun; 26(6):485-500. PubMed ID: 15936477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New therapeutic approaches to autoimmune diseases].
    Amoura Z; Piette JC
    Presse Med; 2006 Apr; 35(4 Pt 2):709-13. PubMed ID: 16614619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-cell targeted therapeutics in clinical development.
    Blüml S; McKeever K; Ettinger R; Smolen J; Herbst R
    Arthritis Res Ther; 2013; 15 Suppl 1(Suppl 1):S4. PubMed ID: 23566679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-cell-directed therapy for inflammatory skin diseases.
    Nagel A; Hertl M; Eming R
    J Invest Dermatol; 2009 Feb; 129(2):289-301. PubMed ID: 19148218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New therapies for autoimmune diseases].
    Amoura Z; Piette JC
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 1():3S7-3S11. PubMed ID: 17075521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [B lymphocyte abnormalities in connective tissue disorders].
    Sato S
    Nihon Rinsho; 2009 Mar; 67(3):477-81. PubMed ID: 19280919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of systemic autoimmune and inflammatory diseases with rituximab].
    Bussone G; Hachulla E; Sibilia J; Michel M; Godeau B; Guillevin L; Mouthon L
    Presse Med; 2009 May; 38(5):808-23. PubMed ID: 19297127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New therapies for systemic lupus erythematosus: cellular targets.
    Looney RJ; Anolik J; Sanz I
    Rheum Dis Clin North Am; 2006 Feb; 32(1):201-15, xi. PubMed ID: 16504831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Systemic lupus erythematosus: future therapeutic avenues].
    Amoura Z; Haroche J; Piette JC
    Rev Med Interne; 2008 Sep; 29(9):718-24. PubMed ID: 18619716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production.
    Lavie F; Miceli-Richard C; Ittah M; Sellam J; Gottenberg JE; Mariette X
    Ann Rheum Dis; 2007 May; 66(5):700-3. PubMed ID: 17040963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab and its use in autoimmune bullous disorders.
    Daniel BS; Murrell DF; Joly P
    Dermatol Clin; 2011 Oct; 29(4):571-5. PubMed ID: 21925000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting B cells for the treatment of rheumatoid arthritis.
    Oligino TJ; Dalrymple SA
    Arthritis Res Ther; 2003; 5 Suppl 4(Suppl 4):S7-11. PubMed ID: 15180891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biological therapy in idiopathic inflammatory myopathies].
    Bodoki L; Nagy-Vincze M; Griger Z; Péter A; András C; Dankó K
    Orv Hetil; 2014 Jan; 155(1):3-10. PubMed ID: 24379090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cell-targeted therapy with rituximab and autoimmune neuromuscular disorders.
    Stübgen JP
    J Neuroimmunol; 2008 Nov; 204(1-2):1-12. PubMed ID: 18783837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab therapy for autoimmune haematological diseases.
    Barcellini W; Zanella A
    Eur J Intern Med; 2011 Jun; 22(3):220-9. PubMed ID: 21570637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Perspectives in clinical immunology].
    Rolla G; Ferrero N; Bergia R; Guida G
    Recenti Prog Med; 2006 Dec; 97(12):787-96. PubMed ID: 17252738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel opportunities for therapeutic targeting in systemic autoimmune diseases.
    Ouarzane M; Zouali M
    Methods Mol Biol; 2007; 361():285-97. PubMed ID: 17172718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-cell targeted therapies in human autoimmune diseases: an updated perspective.
    Townsend MJ; Monroe JG; Chan AC
    Immunol Rev; 2010 Sep; 237(1):264-83. PubMed ID: 20727041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manipulation of the immune response by monoclonal antibodies in auto-immune pathology.
    Benoit P; Boucheix C
    Curr Eye Res; 1990; 9 Suppl():201-5. PubMed ID: 2200645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.